Scientific paper - Original scientific paper
Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes

Yossef, Rami; Gur, Chamutal; Shemesh, Avishai; Guttman, Ofer; Hadad, Uzi; Nedvetzki, Shlomo; Miletić, Antonija; Nalbandyan, Karen; Cerwenka, Adelheid; Jonjić, Stipan; Mandelboim, Ofer; Porgador, Angel

Cite this document

Yossef, R., Gur, C., Shemesh, A., Guttman, O., Hadad, U., Nedvetzki, S. ... Porgador, A. (2015). Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes. PLOS ONE, 10. (2). doi: 10.1371/journal.pone.0118936

Yossef, Rami, et al. "Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes." PLOS ONE, vol. 10, no. 2, 2015. https://doi.org/10.1371/journal.pone.0118936

Yossef, Rami, Chamutal Gur, Avishai Shemesh, Ofer Guttman, Uzi Hadad, Shlomo Nedvetzki, Antonija Miletić, et al. "Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes." PLOS ONE 10, no. 2 (2015). https://doi.org/10.1371/journal.pone.0118936

Yossef, R., et al. (2015) 'Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes', PLOS ONE, 10(2). doi: 10.1371/journal.pone.0118936

Yossef R, Gur C, Shemesh A, Guttman O, Hadad U, Nedvetzki S, and sur.. Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes. PLOS ONE [Internet]. 2015 February 26 [cited 2020 December 04];10(2). doi: 10.1371/journal.pone.0118936

R. Yossef, et al., "Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes", PLOS ONE, vol. 10, no. 2, February 2015. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:468753. [Accessed: 04 December 2020]

Islandora Bookmark - Please login to use this feature